Key result
Mechanical circulatory support in patients with severe heart failure is associated with ischemic stroke and major hemorrhage in up to 30% of patients, necessitating careful antithrombotic management.
Why the study?
MCS disturbs the hematologic and coagulation system, leading to high rates of ischemic stroke and bleeding, requiring hematologists to understand device terminology, antithrombotic therapies, and complications.
Answers are grounded in this paper and cite their sources.
This narrative review provides a foundation for hematologists to understand mechanical circulatory support devices and manage associated thrombosis and hemorrhage.
Mechanical circulatory support (MCS) is the overarching term that encompasses the temporary and durable devices used in patients with severe heart failure. MCS disturbs the hematologic and coagulation system, leading to platelet activation, activation of the contact pathway of coagulation, and acquired von Willebrand syndrome. Ischemic stroke and major hemorrhage occur in up to 30% of patients. Hematologists are an essential part of the MCS team because they understand the delicate balance between bleeding and clotting and alteration of hemostasis with antithrombotic therapy. However, prior to this important collaborative role, learning the terminology used in the field and types of MCS devices allows improved communication with the MCS team and best patient care. Understanding which antithromobotic therapies are used at baseline is also required to provide recommendations if hemorrhage or thrombosis occurs. Additional challenging consultations in MCS patients include the influence of thrombophilia on the risk for thrombosis and management of heparin-induced thrombocytopenia. This narrative review will provide a foundation to understand MCS devices how to prevent, diagnose, and manage MCS thrombosis for the practicing hematologist.
No takes yet. Share an insight, caveat, or question.
Kreuziger et al. (2018) conducted a review in Severe heart failure requiring mechanical circulatory support. Mechanical circulatory support (MCS) was evaluated. Mechanical circulatory support in patients with severe heart failure is associated with ischemic stroke and major hemorrhage in up to 30% of patients, necessitating careful antithrombotic management.
Synapse has enriched 10 related papers. Consider them for comparative context: